Rabies Virus Clearance from the Central Nervous System

Advances in Virus Research

Volumn 79, Issue , 2011, Pages 55-71

  Hooper, D Craig ^a   Roy, Anirban ^a,b   Barkhouse, Darryll A ^a   Li, Jianwei ^a   Kean, Rhonda B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Dog rabies; Human rabies; Lyssavirus; Postexposure prophylaxis; Rabies; Rabies virus; Virus neutralizing antibodies

Indexed keywords

ANIMAL; BOOK; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DOG; HUMAN; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNOLOGY; PATHOGENICITY; RABIES VIRUS; VIROLOGY; VIRULENCE;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; DOGS; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; RABIES VIRUS; VIRULENCE;

EID: 79956117399     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387040-7.00004-4     Document Type: Book

References (36)

1. Akaike T., Weihe E., Schaefer M., Fu Z.F., Zheng Y.M., Vogel W., Schmidt H., Koprowski H., Dietzschold B. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. J. Neurovirol. 1995, 1(1):118-125.
2. Baer G.M., Bellini W.J., Fishbein D.B. Rhabdoviruses. Virology 1990, 883-930. Raven press, New York. 2nd edn. B.N. Fields (Ed.).
3. Baloul L., Camelo S., Lafon M. Up-regulation of Fas ligand (FasL) in the central nervous system: A mechanism of immune evasion by rabies virus. J. Neurovirol. 2004, 10(6):372-382.
4. Baltazard M., Ghodssi M. Prevention of human rabies: Treatment of persons bitten by rapid wolves in Iran. Bull. World Health Organ. 1954, 10:799-803.
5. Centers for Disease Control and Prevention Human rabies-Mississippi, 2005. MMWR Morb. Mortal. Wkly. Rep. 2006, 55:207-208.
6. Centers for Disease Control and Prevention Human rabies-Minnesota, 2007. MMWR Morb. Mortal. Wkly. Rep. 2008, 57:460-462.
7. Centers for Disease Control and Prevention Human rabies prevention-United States, 2008. Recommendations of the Advisory Committee on immunization practices. MMWR Morb. Mortal. Wkly. Report. 2008, 57(RR-3):1-28.
8. Cox J.H., Dietzschold B., Schneider L.G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect. Immun. 1977, 16(3):754-759.
9. Dietzschold B., Wunner W.H., Wiktor T.J., Lopes A.D., Lafon M., Smith C., Koprowski H. Characterization of an antigenic determinant of the glycoprotein which correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. USA 1983, 80:70-74.
10. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., Dietzschold B. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J. Virol. 2002, 76:3374-3381.
11. Faber M., Bette M., Preuss M.A., Pulmanausahakul R., Rehnelt J., Schnell M.J., Dietzschold B., Weihe E. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J. Virol. 2005, 79:15405-15416.
12. Faber M., Li J., Kean R.B., Hooper D.C., Alugupalli K.R., Dietzschold B. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc. Natl. Acad. Sci. USA 2009, 106(27):11300-11305.
13. Fabis M.J., Phares T.W., Kean R.B., Koprowski H., Hooper D.C. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc. Natl. Acad. Sci. USA 2008, 105(40):15511-15516.
14. Fu Z.F., Jackson A.C. Neuronal dysfunction and death in rabies virus infection. J. Neurovirol. 2005, 11(1):101-106.
15. Hampson K., Dushoff J., Cleaveland S., Haydon D.T., Kaare M., Packer C., Dobson A. Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol. 2009, 7(3):e53.
16. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998, 72(5):3711-3719.
17. Hooper D.C., Scott G.S., Zborek A., Mikheeva T., Kean R.B., Koprowski H., Spitsin S.V. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 2000, 14(5):691-698.
18. Hooper D.C., Kean R.B., Scott G.S., Spitsin S.V., Mikheeva T., Morimoto K., Bette M., Röhrenbeck A.M., Dietzschold B., Weihe E. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J. Immunol. 2001, 167(6):3470-3477. 15.
19. Jackson A.C., Reimer D.L., Ludwin S.K. Spontaneous recovery from the encephalomyelitis in mice caused by street rabies virus. Neuropathol. Appl. Neurobiol. 1989, 15:459-475.
20. Koprowski H., Black J. Studies on chick-embryo-adapted rabies virus. V. Protection of animals with antiserum and living attenuated virus after exposure to street strain of rabies virus. J. Immunol. 1954, 72(1):85-93.
21. Krebs J.W., Long-Marin S.C., Childs J.E. Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States. J. Public Health Manag. Pract. 1998, 4:56-62.
22. Morimoto K., Hooper D.C., Carbaugh H., Fu Z.F., Koprowski H., Dietzschold B. Rabies virus quasispecies: Implications for pathogenesis. Proc. Natl. Acad. Sci. USA 1998, 95(6):3152-3156.
23. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 1999, 73(1):510-518.
24. Pasteur L. 1885, 1431-1439.
25. Phares T.W., Kean R.B., Mikheeva T., Hooper D.C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. 2006, 176(12):7666-7675.
26. Phares T.W., Fabis M.J., Brimer C.M., Kean R.B., Hooper D.C. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-α is neither necessary nor sufficient. J. Immunol. 2007, 178(11):7334-7343.
27. Pulmanausahakul R., Faber M., Morimoto K., Spitsin S., Weihe E., Hooper D.C., Schnell M.J., Dietzschold B. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J. Virol. 2001, 75:10800-10807.
28. Roy A., Hooper D.C. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J. Virol. 2007, 81:7993-7998.
29. Roy A., Hooper D.C. Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J. Neurovirol. 2008, 14(5):401-411.
30. Roy A., Phares T.W., Koprowski H., Hooper D.C. Failure to open the blood-brain barrier and deliver immune effectors to the CNS tissues leads to the lethal outcome of Silver-haired bat rabies virus infection. J. Virol. 2007, 81(3):1110-1118.
31. Spitsin S.V., Scott G.S., Kean R.B., Mikheeva T., Hooper D.C. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 2000, 292(2):137-141.
32. Wang Z.W., Sarmento L., Wang Y., Li X.Q., Dhingra V., Tseggai T., Jiang B., Fu Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79(19):12554-12565.
33. Wang T., Rumbaugh J.A., Nath A. Viruses and the brain: From inflammation to dementia. Clin. Sci. 2006, 110(4):393-407.
34. Wilde H. Failures of post exposure prophylaxis. Vaccine 2007, 25:7605-7609.
35. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E. Brief Report: Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 2005, 352:2508-2514.
36. Zhao L., Toriumi H., Kuang Y., Chen H., Fu Z.F. The roles of chemokines in rabies virus infection: Overexpression may not always be beneficial. J. Virol. 2009, 83(22):11808-11818.